We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+553.89%
AUM
$171M
AUM Growth
+$17.7M
Cap. Flow
-$896K
Cap. Flow %
-0.53%
Top 10 Hldgs %
37.72%
Holding
82
New
15
Increased
20
Reduced
25
Closed
10

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$3.98M
2
STZ icon
Constellation Brands
STZ
+$3.24M
3
DD icon
DuPont de Nemours
DD
+$1.97M
4
ETN icon
Eaton
ETN
+$1.77M
5
CVS icon
CVS Health
CVS
+$1.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$4.23M
2
RIO icon
Rio Tinto
RIO
+$2.65M
3
ACN icon
Accenture
ACN
+$2.61M
4
NKE icon
Nike
NKE
+$2.57M
5
PANW icon
Palo Alto Networks
PANW
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 22.17%
2 Financials 17.1%
3 Technology 16.45%
4 Energy 12.54%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
76
Goldman Sachs
GS
$300B
-1,813
Closed -$303K
NKE icon
77
Nike
NKE
$61.9B
-34,623
Closed -$2.57M
RIO icon
78
Rio Tinto
RIO
$158B
-54,555
Closed -$2.65M
ROK icon
79
Rockwell Automation
ROK
$53.4B
-6,145
Closed -$925K
VMC icon
80
Vulcan Materials
VMC
$34.8B
-2,500
Closed -$247K
CLVS
81
DELISTED
Clovis Oncology, Inc.
CLVS
-12,450
Closed -$224K
ACHN
82
DELISTED
Achillion Pharmaceuticals
ACHN
-26,500
Closed -$42K

Similar funds

Bourgeon Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Bourgeon Capital Management held 82 positions worth $171M, up 12% from $153M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Bourgeon Capital Management's Q1 2019 filing shows 15 new, 20 increased, 25 reduced and 10 closed positions. Its largest new stake was iShares Biotechnology ETF: 36,330 shares worth $4.06M. The largest sale was Biogen, an estimated $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Financials and Technology.

  • Bourgeon Capital Management's largest Q1 2019 buy was iShares Biotechnology ETF: 36,330 shares worth $4.06M.
  • Bourgeon Capital Management added most to DuPont de Nemours in Q1 2019, an estimated $1.97M increase.
  • Bourgeon Capital Management's biggest Q1 2019 reduction was Accenture, cutting an estimated $2.61M.
  • Bourgeon Capital Management fully exited Biogen in Q1 2019, selling an estimated $4.23M.
  • Bourgeon Capital Management's ten largest holdings make up 38% of its $171M portfolio in Q1 2019.
  • Bourgeon Capital Management opened 15 new positions and closed 10 in Q1 2019.
  • Bourgeon Capital Management's portfolio value rose 12% quarter-over-quarter to $171M.

Based on Bourgeon Capital Management's 13F filing for Q1 2019, filed 29 Apr 2019.